RT @MedPostsSQU: Atypical hemolytic uremic syndrome pathophysiology and possible features https://t.co/qKZtqV8oH0 https://t.co/e3vkbuZgBC
Atypical hemolytic uremic syndrome pathophysiology and possible features https://t.co/qKZtqV8oH0 https://t.co/e3vkbuZgBC
RT @aHUSAllianceAct: #India #inequality-In most nations, #clinicians with atypical HUS do not have access to either of the 2 therapeutic #d…
#India #inequality-In most nations, #clinicians with atypical HUS do not have access to either of the 2 therapeutic #drugs to treat this #raredisease. In 2019 @rupeshrainamd on #aHUS, overview of #eculizumab challenges & #orphandrug policy issues #neph
RT aHUSAllianceAct RT aHUSAmerica: Cost drives #drug access & national #healthcare policy decisions for #RareDisease patient organizations. Honored to collaborate on behalf of #aHUS patients & atypical HUS issues. Paper: https://t.co/cOsj40v66H, ch
RT @aHUSAmerica: Cost drives #drug access & national #healthcare policy decisions for #RareDisease patient organizations. Honored to collab…
Cost drives #drug access & national #healthcare policy decisions for #RareDisease patient organizations. Honored to collaborate on behalf of #aHUS patients & atypical HUS issues. Paper: https://t.co/cmxeczMmJj, challenges re #patientexperience #ecu
RT @aHUSAllianceAct: Article on atypical HUS includes #patientexperience with #drug access & cost, @aHUSallianceAct #patientsincluded POV.…
RT aHUSAllianceAct Article on atypical HUS includes #patientexperience with #drug access & cost, aHUSallianceAct #patientsincluded POV. Optimal management of atypical hemolytic uremic disease: challenges and solutions https://t.co/cOsj40v66H #raredis
Article on atypical HUS includes #patientexperience with #drug access & cost, @aHUSallianceAct #patientsincluded POV. Optimal management of atypical hemolytic uremic disease: challenges and solutions https://t.co/bOr2YWew1f #raredisease #aHUS #eculi
RT aHUSAllianceAct Optimal management of atypical hemolytic uremic disease: challenges and solutions https://t.co/cOsj40v66H New article re atypical HUS includes #patientexperience with #drug access & cost, aHUSallianceAct #patientsincluded POV . #a
Optimal management of atypical hemolytic uremic disease: challenges and solutions https://t.co/bOr2YWew1f New article re atypical HUS includes #patientexperience with #drug access & cost, @aHUSallianceAct #patientsincluded POV . #aHUS #eculizumab